managing side effects of oral appliance therapy

96
MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

Upload: others

Post on 04-Jun-2022

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

MANAGING SIDE EFFECTS OF ORAL APPLIANCE

THERAPY

Page 2: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• Itisimportanttodocumentthepresenceofmuscleorjointtendernessbeforethedeliveryofthedevice.

• Thephysicalexamina:onshouldincludeaevalua:onofjawfunc:on,andapalpa:onexamina:onoftheTMJsandcervicalandmas:catorymuscles.

• Acommoncomplaintofpa:entswithOSAismorningheadache.- However,musclepainandmostpar5cularlymyofascialpain(MFP)arefrequentlyassociatedwithorcauseheadache.

- Acarefulpalpa5onexamina5on,performedaspartoftheini5alexamina5on,helpstodocumentpreexis5ngmusclepainandassociatedheadache.

DOCUMENT

Page 3: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

EPIDEMIOLOGYOFTMDSYMPTOMS&BITECHANGEASSOCIATEDWITHMADUSE

• Prevalencees:matebetween10-30%ofpa:entsusingMADdevelopedTMDsymptoms.- ClarkGT,ArandD,ChungE,etal.EffectofanteriormandibularposiAoningonobstrucAvesleepapnea.AmRev

RespirDis1993;147(3):624–9.- ClarkGT,KobayashiH,FreymillerE.Mandibularadvancementandsleepdisor-deredbreathing.CDAJ1996;24(4):

49–61.

• Irreversiblebitechange10%- PeAtFX,PepinJL,BeZegaG,etal.Mandibularadvancementdevices:rateofcontraindicaAonsin100consecuAve

obstrucAvesleepapneapaAents.AmJRespirCritCareMed2002;166(3):274–8.- ClarkGT.Mandibularadvancementdevicesandsleepdisorderedbreathing.SleepMedRev1998;2(3):163–74.

Page 4: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

COMMONLYREPORTEDTEMPORARYSIDEEFFECTSFrequency from 6% - 86% of patients

• TMJpain

• MyofascialPain

• ToothPain

• Saliva:on

• TMJointsounds

• DryMouth

• GumIrrita:on

• MorningaLerocclusalchanges

Liu,Y.,Zeng,X.,Fu,M.,Huang,X.,andLowe,A.A.(2000)Effectsofamandibularreposi:oneronobstruc:vesleepapnea.AmJOrthodDentofacialOrthop118,248-256

Lowe,A.A.,Sjoholm,T.T.,Ryan,C.F.,Fleetham,J.A.,Ferguson,K.A.,andRemmers,J.E.(2000)Treatment,airwayandcomplianceeffectsofa:tratableoralappliance.Sleep23,S172-178

Neill,A.,Whyman,R.,Bannan,S.,Jeffrey,O.,andCampbell,A.(2002)Mandibularadvancementsplintimprovesindicesofobstruc:vesleepapnoeaandsnoringbutsideeffectsarecommon.NZMedJ115,289-292

O’Sullivan,R.A.,Hillman,D.R.,Mateljan,R.,Pan:n,C.,andFinucane,K.E.(1995)Mandibularadvancementsplint:anappliancetotreatsnoringandobstruc:vesleepapnea.AmJRespirCritCareMed151,194-198

Pancer,J.,Al-Faifi,S.,Al-Faifi,M.,andHoffstein,V.(1999)Evalua:onofvariablemandibularadvancementappliancefortreatmentofsnoringandsleepapnea.Chest116,1511-1518

Schönhofer,B.,Hochban,W.,Vieregge,H.J.,Brünig,H.,andKöhler,D.(2000)Immediateintraoraladapta:onofmandibularadvancingappliancesofthermoplas:cmaterialforthetreatmentofobstruc:vesleepapnea.Respira:on67,83-88

Liu,Y.,andLowe,A.A.(2000)Factorsrelatedtotheefficacyofanadjustableoralapplianceforthetreatmentofobstruc:vesleepapnea.ChinJDentRes3,15-23

Pan:n,C.C.,Hillman,D.R.,andTennant,M.(1999)Dentalsideeffectsofanoraldevicetotreatsnoringandobstruc:vesleepapnea.Sleep22,237-240

Bondemark,L.,andLindman,R.(2000)Craniomandibularstatusandfunc:oninpa:entswithhabitualsnoringandobstruc:vesleepapnoeaaLernocturnaltreatmentwithamandibularadvancementsplint:a2-yearfollow-up.EurJOrthod22,53-60.

Page 5: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

TMJPAIN

Page 6: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

TMJPAIN

• Cause- mandibleeccentricity- posteriorcontactheavyonpainfulside- mandibularadvancementbeyondabilityofjointstructures

• Solu5on- correctmidlinewithapplianceasisduringhabitualocclusion- adjustposteriorcontact- setappliancebacktolastcomfortablespot,decreaserateofadvancement,symptoma:ctreatment

Page 7: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

TREATMENT-CAPSULITIS

• Pa:entshouldbeinstructedtogoonasoLdiet,- avoidingchewinganyhardfoods,- smallbites,andsteamingvegetables.- deferfromsaladsun5lthepainresolves.

• Pa:entalsoshouldbeinstructedtoreducejawfunc:on:- bynotchewinggum

• Usemoistheatonthejaw2to3:mesperday.

Page 8: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

TREATMENT:• Palla:ve1.SoLdiet2.Moistheat10-15minutes2-3:mesaday.3.NSAIDSorSteroids• Physiotherapy(Ultrasoundw/wophonoand/or

iontophoresis,laser,etc.• Re-evaluatein1week• Splinttherapy

CAPSULITUS

Page 9: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

RETRODISCITUS

Treatment:a.NSAIDSorsteroidsb.SoLDietc.IceaLerjawac:vityd.SplintTherapy(movecondyleoffretrodiscal:ssue)e.Jointmobiliza:onf.Physiotherapy(ultrasoundw/wophono.and/ionto,lasertx.)

Page 10: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

TREATMENTCAPSULITUS

Generic Brand Dosing Guidelines

Acetaminophen Tylenol Start 650 mg QID; increase to 4000-6000 mg/day

Aspirin Aspirin 325-650 mg q 4-6 hours; maximum 4000-6000 mg/day

Diflunisal Dolobid Start 500 mg bid; maximum is 1500 mg/day

Diclofenac sodium Voltaren 25-50mg q 6-8 hours to maximum of 150 mg/day

Ibuprofen Advil, Motrin 300-600 mg tid-qid; maximum is 3200 mg/day

Naproxen Naprosyn, Aleve 250-500 mg bid; maximum is 1025-1375 mg/day

Ketoprofen Orudis 25-50 mg tid-qid; maximum is 300 mg/day

Ketorolac Toradol IM form recommended; 60 mg single dose; 30 mg multiple dosing not to exceed 120 mg/day

Indomethacin Indocin Start 25 mg tid; increase to maximum of 50 mg tid

Sulindac Clinoril 150-200 mg bid; maximum is 400 mg/day

Etodolac Lodine 200-300 mg tid to maximum of 1200 mg/day

Celecoxib Celebrex 100 mg bid to maximum of 400 mg/day

Page 11: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

JRS 40

Page 12: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• Reevaluateoralappliance- toseeifitisadvancingthejawtoomuch.

• Determinebalancebetweentheamountofadvancementversustheincreaseinver:cal.

• Increasingthever:calisusuallylessirrita:ngtotheTMJthanadvancingthemandible.

TREATMENT-CAPSULITIS

Page 13: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY
Page 14: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

TMJPAIN

CC:PAININAMONRIGHTMASSETERAREA

Page 15: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

CC:PAININAMONRIGHTMASSETERAREA

Page 16: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

SOLUTION:CORRECTMIDLINE.

Page 17: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

MYOFACIAL PAIN

Page 18: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• Myalgiaisdescribedasadull,aching,andcon5nuouspainassociatedwithmusclefunc:on.

• Confirmedbypalpa:onofthemusclesandlookingforreplica:onofthepaincomplaint.

MASTICATORYMUSCLEDISORDERMYALGIA

Page 19: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY
Page 20: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY
Page 21: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

•  Physicaltherapy,physicalmedicinetechniques,

• Medica6onmanagementtoop6mizethetreatment.

•  Stretchingthemas6catorymusclesduringtheday.-  stretchthejawbyplacingthetongueonthepalatebehindtheupperfrontteethandstretchingopenasfarastheycanstretchwithoutpullingthetongueoffofthepalate.

-  stretchisheldfor6seconds,repeated6:mes,andtheprocessisrepeated6:mesperday.

-  exercisestretchesthemasseter,medialpterygoid,andtemporalismuscles.

stretching the masticatory muscles during the day. This process should start afterremoval of the MAD and the exercises to reestablish posterior tooth-to-tooth contacts.The patient should be instructed to stretch the jaw by placing the tongue on the palatebehind the upper front teeth and stretching open as far as they can stretch withoutpulling the tongue off of the palate (Fig. 6). The stretch is held for 6 seconds, repeated6 times, and the process is repeated 6 times per day. This exercise stretches themasseter, medial pterygoid, and temporalis muscles. If the muscles are severelytender, the patient should use moist heat for 5 minutes before the stretching exercisesand then ice to cool down the muscles for 5 minutes after the stretching.The patient should also be instructed to assume a jaw rest position during the day.

This practice helps the patient to avoid daytime clenching that can keep the musclestender. The patient is instructed to place the tongue on the palate similar to the jawposition assumed for the stretch in Fig. 6, but the lips are brought together and theteeth kept slightly apart. The patient is also instructed to breathe through the nosein this position. This rest position helps to reduce masseter, medial pterygoid, andtemporalis muscle activity.

ADJUNCTIVE MEDICATIONS

In addition to the medications discussed earlier, other classes of medications can behelpful in mediating the pain. Muscle relaxants can be a helpful addition to treating the

Fig. 6. Stretching exercises. The left image shows the tongue on the palate behind theupper front teeth and the jaw being stretched to the point at which the tongue wouldbe pulled off the palate if the patient opened wider. The right image shows the patientstretching the posterior neck muscles that are often painful in association with the jawmuscles.

Table 2Muscle relaxants

Generic Proprietary Dose

Cyclobenzaprine Flexeril 10 mg at bedtime

Tizanidine Zanaflex 2–4 mg (dosed 3 times a day up to 16 mg)

Baclofen Lioresal 5–10 (dosed 3 times a day up to 80 mg)

Metaxalone Skelaxin 800 mg 3 to 4 times a day

Methocarbamol Robaxin 500–750 mg (1500 mg 4 times a day)

Soma Carisoprodol 250–350 mg 3 times a day. Use for maximum of 2 weeks

TMD Pain and Dental Treatment of OSA 427

Page 22: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

stretching the masticatory muscles during the day. This process should start afterremoval of the MAD and the exercises to reestablish posterior tooth-to-tooth contacts.The patient should be instructed to stretch the jaw by placing the tongue on the palatebehind the upper front teeth and stretching open as far as they can stretch withoutpulling the tongue off of the palate (Fig. 6). The stretch is held for 6 seconds, repeated6 times, and the process is repeated 6 times per day. This exercise stretches themasseter, medial pterygoid, and temporalis muscles. If the muscles are severelytender, the patient should use moist heat for 5 minutes before the stretching exercisesand then ice to cool down the muscles for 5 minutes after the stretching.The patient should also be instructed to assume a jaw rest position during the day.

This practice helps the patient to avoid daytime clenching that can keep the musclestender. The patient is instructed to place the tongue on the palate similar to the jawposition assumed for the stretch in Fig. 6, but the lips are brought together and theteeth kept slightly apart. The patient is also instructed to breathe through the nosein this position. This rest position helps to reduce masseter, medial pterygoid, andtemporalis muscle activity.

ADJUNCTIVE MEDICATIONS

In addition to the medications discussed earlier, other classes of medications can behelpful in mediating the pain. Muscle relaxants can be a helpful addition to treating the

Fig. 6. Stretching exercises. The left image shows the tongue on the palate behind theupper front teeth and the jaw being stretched to the point at which the tongue wouldbe pulled off the palate if the patient opened wider. The right image shows the patientstretching the posterior neck muscles that are often painful in association with the jawmuscles.

Table 2Muscle relaxants

Generic Proprietary Dose

Cyclobenzaprine Flexeril 10 mg at bedtime

Tizanidine Zanaflex 2–4 mg (dosed 3 times a day up to 16 mg)

Baclofen Lioresal 5–10 (dosed 3 times a day up to 80 mg)

Metaxalone Skelaxin 800 mg 3 to 4 times a day

Methocarbamol Robaxin 500–750 mg (1500 mg 4 times a day)

Soma Carisoprodol 250–350 mg 3 times a day. Use for maximum of 2 weeks

TMD Pain and Dental Treatment of OSA 427

TREAT-MYOGENOUSPAIN

Page 23: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• Paininelevatormuscles- Moistheatstretches- Musclerelaxantand/orNSAID- Topicalmedica:ons- 10%Ketroprofen&2%cyclobenzaprine

• PaininTMJ- NSAIDSorSteroids- d/cwearingofappliance:llsymptomsresolve

• RefertoPhysicaltherapy

SYMPTOMATICRELIEF

Page 24: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

MUSCLE SPASM

ULTRASOUND

Page 25: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

ULTRASOUND

Page 26: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

MUSCLE SPASM

ELECTRICAL MUSCLE STIMULATION

Page 27: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

SPRAY AND STRETCH

Page 28: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

TOOTHPAIN

Page 29: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• Cause- wearonstone- distortedimpression

• Solu5on- adjustareaofconcern- remakeapplianceifimpressionwasdistorted

PAINININDIVIDUALTOOTH

Page 30: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

PAININANTERIORTEETH

• Cause- clenching- poorposteriorsupport/noposteriorsupport

• Solu5on- addposteriorstopsifnotpresent- adjustanterioraspectofapplianceusing“BULL”rule.

Page 31: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

MOBILITYOFANTERIORTEETH

• Cause- retrudingforceoflowerjawonteeth

• Solu5on- adjustanterioraspectofapplianceusing“BULL”rule.

Page 32: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

SALIVATION

Page 33: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• Cause- presenceofapplianceinmouth

• Solu5on- towelonorinsidepillowcase- resolvedin1-2weeks

EXCESSSALIVATION

Page 34: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

TMJSOUNDS

Page 35: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

TMJARTICULARDISORDERS

• Diskderangementsarecommoninthegeneralpopula:on,withprevalencees:matesrangingfrom40%to75%ofthepopula:on.

• Majortraumaalsomaydamagethediskorligaments:- fight,fall,sportsinjury,oralsurgery,ormotorvehicleaccident

• Excessiveparafunc:onalac:vity:- gumchewing,bruxism,bracing,orclenching

• Laxitymayallowthedisktoslipforward,leadingtodiskclicking.

Page 36: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

TMJARTICULARDISORDERSCLICKINGJOINTS

Normal ADDw/red.

Page 37: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

TMJARTICULARDISORDERSNON-CLICKINGJOINTS

ADDw/outred.Normal

Page 38: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

TMJARTICULARDISORDERSCLICKINGJOINTS

• Treatmentofclickingjointsisnotadvocatedunlessseverepainanddysfunc:onareassociatedwiththedisloca:on.

• DeLeeuwR,editor.Orofacialpain;guidelinesforassessment,diagnosis,andmanagement.4thedi:on.HanoverPark(IL):QuintessenceBooks;2008.

• Inpainfulclickingandjointdysfunc:on,considerfabrica:ngananterioradvancementsplintfornightmeandday:meuseun:ljointinflamma:onsubsidesandthejointadaptstothemechanicaldysfunc:on.

• UseofaMADsleepappliancecanprovidethiskindofstabiliza:on.

Page 39: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

DRYMOUTH

Page 40: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

Cause:• mouthbreathing• lipincompetency• nasalissues

Solu:on:• ar:ficialsaliva• differentappliance• refertoENT

DRY MOUTH

Page 41: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

http://www.oracoat.com/pages/xylimelts-directions-for-use

Page 42: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• SpecialDentalOfficePricing:• 50%belowretailprices• Samesize40discsasindrugstores

• PatientSamples:• 4discsinasamplebrochure,40brochuresperbox• Firstsampleboxof8brochures(4discseach)FREE

• ForPricingCall:877-672-6541

DENTALOFFICEPRICING

Page 43: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

Xerostomproduct AveragepH

Xerostommouthwash 7.0

Xerostomsalivasubs:tutegel 6.35

Xerostomtoothpaste 7.50

Page 44: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

EMAIL FOR SAMPLE

[email protected]

Page 45: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

NASALISSUES

Page 46: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

PATENTNASALAIRWAY

• Essential to success with OSA therapy• Independent contributor to Sleep disorders• Affects sleep outcomes

Dixon et al. Criteria to screen for chronic sinonasal diseaseChest 2009;136: 1324-32

Page 47: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

NASAL STEROID SPRAYS

Nasal steroid sprays improved the following:1. Congestion2. Daytime sleepiness3. Subjective sleep quality4. Have shown that they can greatly

improve AHI in various studies

Page 48: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

POSSIBLENASALOBSTRUCTIONS

• Septaldevia:on• Enlargedturbinates• Sinusi:s• Nasalpolyps• Allergicrhini:s• Enlargedadenoids

Page 49: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

NASALAIDS

Mute Nose Clips

Page 50: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY
Page 51: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY
Page 52: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY
Page 53: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

GUMIRRITATION

Page 54: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• Cause- rubbingofacrylic

• Solu:on- adjustacrylic

GUMIRRITATION

Page 55: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

BITECHANGE

Page 56: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

EFFECTSOFMAD-BITECHANGE

• Bitechangeshavebeenreportedinpa:entsusingMADs.

• Commonly,temporaryocclusalchangesareobservedinthemorningwhenthedeviceisremoved,requiringthepa:enttoperformsomeexercisestobringtheposteriorteethbacktogether.

• However,evidenceismoun:ngthatlong-termuseofMADscausespermanentchangesintheocclusalrela:onship.

Page 57: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

EFFECTS OF MAD - PLAN

• Pa:entsshouldbegiveninstruc:onsregardingthenecessityofperformingexercisestobringtheposteriorteethbackintocontact.- pa5entsmaynotperformtheexercisesasdirectedandthebitechangescanbecomepermanent.

Page 58: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

POSTERIOROPENBITEINAM

• Cause• edemainjointspace• shorteningoflateralpterygoidmuscle• poten:alrecaptureofadislocateddisc

• Solu5on• clenchingonbitetab• chewingbubblegum• bi:ngonleafgauge• leanlowerjawonhand• AMaligner

Page 59: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

POSTERIORBITEINAMEdema

Shortening

Page 60: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

POSTERIORBITEINAM

Page 61: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY
Page 62: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

BITECHANGE-INITIAL4/18/11

Page 63: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

BITECHANGE-11/2/2011-D/C

Page 64: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

BITECHANGE-12/12/2011-F/U

Page 65: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

BITECHANGE-1/4/2012-F/U

Page 66: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

CASE STUDY

Page 67: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• PriorHxoforthodon5cs- Fixedlowerretainer3-3

• Priorhistoryofjointsoundsonopening

• PresentlyledTMJ- earlyopeningclick

• ROM:42mmopening,lateral15+mm,Protrusive5- Overbite5mm,Overjet4mm- deflec:ontorightonopening

CYNTHIA

Page 68: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

CYNTHIA-PSG

Page 69: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

CYNTHIA-BASELINEPHOTO

Page 70: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

CYNTHIA-BASELINEPHOTO

Page 71: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

CYNTHIA-IMPORTANTNOTE

Maintain midlines

Page 72: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• Nojointsoundonright

• NOdeflec:ontorightnoted

• PaininrightTMJ1. bi:ngoncowonrollsonright-Pain2. bi:ngontonguebladeonright-NOPain

CYNTHIA-FOLLOWUP1WEEK

Page 73: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

CYNTHIA-COMPARISON

• Priorhistoryofjointsoundsonopening

• PresentlyleLTMJ- earlyopeningclick

• ROM:42mmopening,lateral15+mm,Protrusive5- deflec:ontorightonopening

Initial • Nojointsoundonright

• NOdeflecAontorightnoted

• PaininrightTMJ- biAngoncoZonrollsonright-Pain

- biAngontonguebladeonright-NOPain

Follow up

Page 74: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

CYNTHIA-CLINICALIMPRESSION

• Impression:Disconrightreduced.- confirmbyMRI

• Differen5aldiagnosis:- Rightlateralpterygoidmusclespasm

Page 75: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

MELLISA

• PriorHxoforthodon:cs- bicuspidextrac5on

• Bruxer/clencher

• PresentlyRightTMJ- lateopeningclick

• Musclepalpa:on-wnl

• ROM:47mmopening,lateral15+mm,Protrusive7mm- Overbite2mm,Overjet2mm- devia5ontorightonopening

Page 76: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• Mallampatscore:ClassIV

• Tonguelevel:3

• Class1molarrela:onship

• Tongue:- fissured- scalloped

• SoLpalate:- edematous- Grade1tonsils

• Palate:- Valuted- Narrow

• Mandible:- Narrow

MELLISA

Page 77: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

MELLISA-INTRAORAL(5/2010)

Page 78: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

MELISSAPSG

Overall AHI. 21.6 Supine AHI. 31.4

O2 desaturation Nadir. 77%

REM sleep AHI. 6.4 Non supine AHI. 16.2

Hypnotic Burden. 5.4% or TST

The total arousal index was elevated at 33.2 arousals per hour due to respiratory events, snore arousals and spontaneous

arousals.

Page 79: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

MELLISA-APPLIANCE

Page 80: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

MELLISA-FOLLOWUP(6/2010)

Page 81: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• RightTMJ- lateopeningclick

• Musclepalpa:on-WNL

• ROM:47mmopening,lateral15+mm,Protrusive7mm- devia:ontorightonopening

• RightTMJ- NOlateopeningclick

• Musclepalpa:on-WNL

• ROM:49mmopening,lateral15+mm,Protrusive8mm- NOdevia:ontorightonopening

Initial (5/2010) Follow up (6/2010)

MELLISA-COMPARISON

Page 82: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

Fusion Sleep

Respiration Report

Patient InformationFull NamePatient IDAddressZIP/Postal CodeCityPhone/Mobile

Melissa DanielssonDANME000

Date of BirthHeightWeightBMI

10/22/196262 in138 lb25.2

Age 47

Recording Information

Recording Date 6/27/2010 Bed Time Starts 11:13 PM

Recording Duration 10h 25m 49s Time in BedRecording Time 11:07 PM

10h 12m (612.8m)Bed Time Ends 9:25 AM

Respiration Overview

AHI ODI Snore Index4.9 3.0 0.1%AHI is the number of Apneas and Hypopnea per hour. ODI is the number of oxygen desaturations per hour. Snore Index is the percentage of time spent snoring versus the total time spent in bed.

Respiratory Indices Respiratory CountApnea/Hypopnea Index

Hypopnea IndexApnea Index

4.92.92.0

Apneas

Central/MIxedObstructive

Hypopneas

30141620Snore Index 0.1

5.63.32.30.1

supinetotal28131519

total supine/h/h/h

/h/h/h%%

Longest Apnea 23 23 ss

Longest Hypopnea 36 36 ssAverage Apnea 15 15 ss

Average Hypopnea 24 24 ss

PulseDesaturation Index Average Pulse

Average SpO2

3.0

94.8

40

Desaturation < 90%: 0.1

Saturation3.3

94.6

41

0.1

supinetotal/h

%

bpm/h

%

bpm

Desaturation < 85%: 0.0 0.0/h /h/h /h

Desaturation Count 31 28

SpO2 time < 90%: 5.0 6.0SpO2 time < 85%: 3.2 3.9

% %% %

total supine

Highest Pulse 70 70bpm bpm

Lowest Pulse 35 35bpm bpmLowest SpO2 81.0 81.0% %

Pulse time < 40bpm 41.4 35.7Pulse time > 100bpm 0.0 0.0

% %% %

Average Pulse SD 1.7 1.7bpm bpm

93.3Good100.0Fair

50.6 %% 51.8Paradoxical Index

OtherSupine Time

Activity Time

Non-Supine Time513.9107.8

57.8

Position and Activity82.217.2

9.3

mm

m

%%

%Upright Time 3.3 0.5m %

total supine

91.8 %% 90.3Est. Sleep Efficiency

Oximeter QualityFlow Quality

Invalid Data Time 0 0.0m %

%%

Fair92.4RIP Quality %

Respiration ReportCreated On: 7/2/2010 11:35 AM Page 1 of 3

Melissa Danielsson, DANME000

MELLISA-HSTA

Page 83: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• Impression:Disconrightreduced.- confirmbyMRI

MELISSA-CLINICALIMPRESSION

Page 84: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

CPAPBITE

Page 85: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

Age: 23BMI: 21.8

CASE

Page 86: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

CASE

Page 87: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• Objective findings: • Mild tenderness was elicited upon palpation of the:

• trapezius neck area on the right, • splenius capitis on the right, • buccinator insertion on the left, • temporal tendon on the left, • styloid process on the right, • posterior joint space on the left, • posterior temporalis on the right, • superficial masseter on the right , • deep masseter on the right

• Moderate tenderness was elicited upon palpation of the: • occipital on the right, • posterior joint space on the right, • lateral TMJ capsule on the right

• Severetendernesswaseliciteduponpalpa5onofthe:• stylomandibularligamentontheright.

Page 88: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• Clinicalexamina:onrevealedtheTMjointswithinnormallimits.

• CRANIALNERVESCREENING:withinnormallimits.

• Cervicalrangeofmo:onmeasurementsindicatedpainonextension,painonsidebend(bilateral)andpainonrota:ononbothsides.

Page 89: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• ORALEXAMINATION:• healthyperiodon:um,• missingtooth#1,16,17,32,• 4mmoverbite,a2mmoverjet,• scallopedtongue,tonguelevel3,grade3mallampa:classifica:on,• teethincrossbite:#5,29,• vaultedpalate,• mandibulartori• ClassIdentalrela:onship.

Page 90: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• MANDIBULARRANGEOFMOTIONMEASUREMENTS:• 44mmopeningwithoutpain,• maximumprotrusiveof3mm,• leLlateralexcursionof12mm,rightlateralexcursionof13mm,• normalmandibularmidline,normalmaxillarymidlineandnormal

skeletalmidlines.

• SprayandStretchimprovedmaximumopeningto54mm.

Page 91: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

• MYWORKINGDIAGNOSISIScapsuli:softhebilateraltemporomandibularjoint(ICD726.90),bilateralmyalgia(ICD729.1)andcervicalgiaontheright(ICD723.1).

• PLAN:medica:onregimen:Flexeril10mg1tabatnightPRNdisp30tabs.

• Ourgoalistoruleoutasleepdisorderedbreathingproblemthatmaybeacontributoryreasonforhissubjec:vecomplaints.WehaveadvisedhimtoreturntoourofficeaLercomple:onofthediagnos:cprocessanddiscussionoffindingsfromthemedicaldoctorsatFusionSleep.Basedontheoutcomeofresultswewilldetermineatreatmentplanforhim.

CASE

Page 92: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

CASE

Page 93: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

CASE-HABITUALOCCLUSION

Page 94: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

CASE-DAYAFTERAUTOPAPTHERAPY

Page 95: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY

“‘SLEEPISEASYASLONGASYOUUNDERSTANDTMD’

DR.JAMISONSPENCERDMD

Page 96: MANAGING SIDE EFFECTS OF ORAL APPLIANCE THERAPY